# The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024, Regulation 18: Amendment to regulation 29


(1) Regulation 29 (conduct of trial in accordance with clinical trial authorisation etc.) is amended as follows.
(2) In paragraphs (a) and (b)—
(a) for “amended” substitute “modified”;
(b) for “regulations 22 to 25” substitute “regulations 20 to 22C”.
(3) In paragraph (c)—
(a) omit “by the licensing authority”;
(b) for “regulation 18(2) or (6), 19(8), 20(5), 24(5)” substitute “regulation 18(3), 18B(3), 22A(4), 22C(3)”.

---
Source: https://www.legislation.gov.uk/ukdsi/2024/9780348267167/regulation/18 (the official version)
Page: https://openlegislation.uk/draft-medicines-for-human-use-clinical-trials-amendment-regulations-2024/regulation-18
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.